Sansure Biotech Inc.

XSSC:688289 Stock Report

Market Cap: CN¥12.2b

Sansure Biotech Management

Management criteria checks 4/4

Sansure Biotech's CEO is Lizhong Dai, appointed in Jul 2019, has a tenure of 5.58 years. directly owns 33.21% of the company’s shares, worth CN¥4.06B. The average tenure of the management team and the board of directors is 5.6 years and 5.6 years respectively.

Key information

Lizhong Dai

Chief executive officer

CN¥700.6k

Total compensation

CEO salary percentagen/a
CEO tenure5.6yrs
CEO ownership33.2%
Management average tenure5.6yrs
Board average tenure5.6yrs

Recent management updates

Recent updates


CEO

Lizhong Dai (56 yo)

5.6yrs

Tenure

CN¥700,600

Compensation

Mr. Lizhong Dai is Chairman of the Board and General Manager of Sansure Biotech Inc. from July 2019.


Leadership Team

NamePositionTenureCompensationOwnership
Lizhong Dai
Chairman of the Board & GM5.6yrsCN¥700.60k33.21%
CN¥ 4.1b
Zhu Peng
CFO, Deputy GM & Director5.6yrsCN¥1.68m0.067%
CN¥ 8.2m
Peng Yin
Deputy GM2yrsCN¥2.28mno data
Xialin Yu
Deputy GM & Director5.6yrsCN¥439.70k0.026%
CN¥ 3.2m
Xu Fan
Deputy GM & Director5.6yrsCN¥666.90k0.054%
CN¥ 6.6m
Jia Liu
Deputy GM & Directorno dataCN¥557.80k0.035%
CN¥ 4.3m
Jun Zhou
Deputy General Manager5.6yrsCN¥970.40k0.016%
CN¥ 1.9m
Kai Liu
Deputy General Manager3.5yrsCN¥1.55m0.026%
CN¥ 3.1m
Jian Zhu
Deputy General Manager3.5yrsCN¥2.34m0.025%
CN¥ 3.0m
Zhongping Deng
Deputy General Manager5.6yrsCN¥522.60k0.019%
CN¥ 2.3m
Haixiao Wang
Deputy General Manager2.6yrsCN¥1.43m0.041%
CN¥ 5.0m
Xiaoyan Xiong
Deputy General Manager2.3yrsCN¥621.60k0.022%
CN¥ 2.7m

5.6yrs

Average Tenure

47yo

Average Age

Experienced Management: 688289's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lizhong Dai
Chairman of the Board & GM5.6yrsCN¥700.60k33.21%
CN¥ 4.1b
Zhu Peng
CFO, Deputy GM & Director5yrsCN¥1.68m0.067%
CN¥ 8.2m
Xialin Yu
Deputy GM & Director5.6yrsCN¥439.70k0.026%
CN¥ 3.2m
Xu Fan
Deputy GM & Director4.3yrsCN¥666.90k0.054%
CN¥ 6.6m
Jia Liu
Deputy GM & Director2.6yrsCN¥557.80k0.035%
CN¥ 4.3m
Wu Tan
Chairman of Supervisory Board5.6yrsno data0.035%
CN¥ 4.3m
Ya Cao
Independent Director5.6yrsCN¥80.00kno data
Yuan Fang
Director5.6yrsno datano data
Ling Lin
Supervisor2.6yrsno data0.00040%
CN¥ 48.9k

5.6yrs

Average Tenure

45yo

Average Age

Experienced Board: 688289's board of directors are considered experienced (5.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 08:59
End of Day Share Price 2025/02/11 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sansure Biotech Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shiyu ChenChina International Capital Corporation Limited
Zhu ChenCitic Securities Co., Ltd.
Shuo SongCitic Securities Co., Ltd.